<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exerc Rehabil</journal-id><journal-id journal-id-type="iso-abbrev">J Exerc Rehabil</journal-id><journal-title-group><journal-title>Journal of Exercise Rehabilitation</journal-title></journal-title-group><issn pub-type="ppub">2288-176X</issn><issn pub-type="epub">2288-1778</issn><publisher><publisher-name>Korean Society of Exercise Rehabilitation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28119880</article-id><article-id pub-id-type="pmc">5227320</article-id><article-id pub-id-type="doi">10.12965/jer.1632770.385</article-id><article-id pub-id-type="publisher-id">jer-12-6-575</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Impact of long-term high-intensity interval and moderate-intensity continuous training on subclinical inflammation in overweight/obese adults</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gerosa-Neto</surname><given-names>Jos&#x000e9;</given-names></name><xref ref-type="aff" rid="af1-jer-12-6-575">1</xref><xref rid="c1-jer-12-6-575" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Antunes</surname><given-names>Barbara M.M.</given-names></name><xref ref-type="aff" rid="af1-jer-12-6-575">1</xref></contrib><contrib contrib-type="author"><name><surname>Campos</surname><given-names>Eduardo Z.</given-names></name><xref ref-type="aff" rid="af1-jer-12-6-575">1</xref></contrib><contrib contrib-type="author"><name><surname>Rodrigues</surname><given-names>Jhennyfer</given-names></name><xref ref-type="aff" rid="af2-jer-12-6-575">2</xref></contrib><contrib contrib-type="author"><name><surname>Ferrari</surname><given-names>Gustavo D.</given-names></name><xref ref-type="aff" rid="af3-jer-12-6-575">3</xref></contrib><contrib contrib-type="author"><name><surname>Rosa Neto</surname><given-names>Jos&#x000e9; C.</given-names></name><xref ref-type="aff" rid="af4-jer-12-6-575">4</xref></contrib><contrib contrib-type="author"><name><surname>Bueno</surname><given-names>Carlos R.</given-names><suffix>Junior</suffix></name><xref ref-type="aff" rid="af2-jer-12-6-575">2</xref></contrib><contrib contrib-type="author"><name><surname>Lira</surname><given-names>F&#x000e1;bio S.</given-names></name><xref ref-type="aff" rid="af1-jer-12-6-575">1</xref></contrib></contrib-group><aff id="af1-jer-12-6-575"><label>1</label>Exercise and Immunometabolism Research Group, Department of Physical Education, Sao Paulo State University, Presidente Prudente, 
<country>Brazil</country></aff><aff id="af2-jer-12-6-575"><label>2</label>School of Physical Education and Sport, University of S&#x000e3;o Paulo (USP), Ribeir&#x000e3;o Preto, 
<country>Brazil</country></aff><aff id="af3-jer-12-6-575"><label>3</label>Ribeir&#x000e3;o Preto Medical School, University of S&#x000e3;o Paulo (USP), Ribeir&#x000e3;o Preto, 
<country>Brazil</country></aff><aff id="af4-jer-12-6-575"><label>4</label>Immunometabolism Research Group, Department of Cellular Biology and Development, Institute of Biomedical Sciences, University of S&#x000e3;o Paulo (USP), S&#x000e3;o Paulo, 
<country>Brazil</country></aff><author-notes><corresp id="c1-jer-12-6-575"><label>*</label>Corresponding author: Jose Gerosa-Neto, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-1369-0648">http://orcid.org/0000-0003-1369-0648</ext-link>, Exercise and Immunometabolism Research Group, Department of Physical Education, Universidade Estadual Paulista (UNESP), Rua Roberto Simonsen, 305, 19060-900 Presidente Prudente, Brazil, Tel: +55-18991808166, Fax: +55-18322295730, E-mail: <email>netoef@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="collection"><month>12</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>31</day><month>12</month><year>2016</year></pub-date><volume>12</volume><issue>6</issue><fpage>575</fpage><lpage>580</lpage><history><date date-type="received"><day>19</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>01</day><month>12</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Korean Society of Exercise Rehabilitation</copyright-statement><copyright-year>2016</copyright-year><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Obesity is a risk factor able to trigger several inflammatory alterations and the imbalance between pro- and anti-inflammatory cytokine productions. Physical exercise is an important strategy for reduction of inflammatory established process. The aim of this study was to evaluate the effect of 16 weeks of three exercise training programs in the inflammatory profile and insulin resistance in overweight/obesity. Thirty two men and women (46.4&#x000b1;10.1 years; 162.0&#x000b1;9.1 cm; 82.0&#x000b1;13.6 kg) were divided into three groups for training on a treadmill: continuous at 70% maximum heart rate (HRmax) 5 times a week (CONT); 1&#x000d7;4 min (1-bout) and 4&#x000d7;4 min (high intensity interval training, HIIT) at 90% HRmax 3 times a week. Interleukin (IL) 6 and IL-10, tumor necrosis factor-alpha (TNF-&#x003b1;), insulin and adiponectin levels were analyzed by enzyme-linked immunosorbent assay, and homeostasis model assessment insulin resistance was calculated. After 16 weeks of training blood concentrations of IL-6 decreased in the HIIT group (<italic>P</italic>=0.035), TNF-&#x003b1; decreased in the CONT (<italic>P</italic>=0.037) and increased in HIIT (<italic>P</italic>=0.001) and adiponectin decreased in the three training models. There was a trend towards decreased body weight and body mass index (BMI) after HIIT only (<italic>P</italic>=0.059 and <italic>P</italic>=0.060, respectively). Despite the decrease of adiponectin and the increase of TNF-&#x003b1; in HIIT group, insulin sensitivity showed a trend for improvement (<italic>P</italic>=0.08). HIIT program decreased IL-6 at rest and although not significant was the only who tended to decrease total body weight and BMI. Taken together, our data suggest that both HIIT as well as CONT exercises training program promotes changes in inflammatory profile in overweight/obesity, but dissimilar response is seen in TNF-&#x003b1; levels.</p></abstract><kwd-group><kwd>Inflammation mediators</kwd><kwd>Aerobic exercise</kwd><kwd>Insulin resistance</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Obesity is a risk factor able to trigger several inflammatory alterations favorable for the chronic low-grade inflammation, by imbalance between pro- and anti-inflammatory cytokine productions. Furthermore, obesity is positively associated with installation and development of diseases as type 2 diabetes, cardiovascular diseases and metabolic syndrome in populations of different ages and genders (<xref rid="b34-jer-12-6-575" ref-type="bibr">Weghuber et al., 2014</xref>; <xref rid="b35-jer-12-6-575" ref-type="bibr">Wen et al., 2013</xref>).</p><p>Chronic low-grade inflammation observed in illness associates with modifications in plasmatic cytokines concentration, as high concentrations of plasminogen activator inhibitor-1 (<xref rid="b18-jer-12-6-575" ref-type="bibr">Lira et al., 2010</xref>), C-reactive protein, interleukin (IL) 6 and tumor necrosis factor-alpha (TNF-&#x003b1;), which are considered pro-inflammatory biomarkers. In addition, this inflammatory context reduces anti-inflammatory cytokine concentration, as adiponectin, and IL-10. Obese individuals have low concentrations of adiponectin, and this is associated with the metabolic syndrome (<xref rid="b26-jer-12-6-575" ref-type="bibr">Renaldi et al., 2009</xref>), type 2 diabetes (<xref rid="b11-jer-12-6-575" ref-type="bibr">Hotta et al., 2000</xref>), dyslipidemia (<xref rid="b15-jer-12-6-575" ref-type="bibr">Lara-Castro et al., 2006</xref>) and coronary artery diseases (<xref rid="b33-jer-12-6-575" ref-type="bibr">Vilarrasa et al., 2005</xref>).</p><p>Several studies have documented the effectiveness of exercise training on metabolic disorders, prevention and treatment, and its anti-inflammatory effect (<xref rid="b4-jer-12-6-575" ref-type="bibr">de Meirelles et al., 2014</xref>; <xref rid="b14-jer-12-6-575" ref-type="bibr">Karstoft and Pedersen, 2016</xref>; <xref rid="b17-jer-12-6-575" ref-type="bibr">Lira et al., 2015</xref>). High intensity interval training (HIIT) has been proposed to be a time-efficient (low volume) method to improve aspects related to body composition and disease (<xref rid="b21-jer-12-6-575" ref-type="bibr">Madsen et al., 2015a</xref>; <xref rid="b22-jer-12-6-575" ref-type="bibr">Madsen et al., 2015b</xref>; <xref rid="b28-jer-12-6-575" ref-type="bibr">Sijie et al., 2012</xref>; <xref rid="b30-jer-12-6-575" ref-type="bibr">Talanian et al., 2007</xref>). <xref rid="b21-jer-12-6-575" ref-type="bibr">Madsen et al. (2015a)</xref> showed only a modest improvement in anti-inflammatory cytokine after eight weeks of HIIT for subjects at risk for metabolic syndrome individuals, while inflammatory cytokines did not change. On the other hand, have observed that HIIT is more effective to treat excessive body weight than moderate continuous training (<xref rid="b28-jer-12-6-575" ref-type="bibr">Sijie et al., 2012</xref>). These differences in results may be due to differences in training intensity and volume, and training length (8 weeks) (<xref rid="b21-jer-12-6-575" ref-type="bibr">Madsen et al., 2015a</xref>). Thus, whether longer than 8-week HIIT, with lower volume than typical training session can improve metabolic and inflammatory profile of subjects with overweight and obesity is unknown. Therefore, the purpose of the present study was (a) analyze the effects of 16 weeks of different models exercise training (high-intensity interval vs. moderate-intensity continuous training) on inflammatory profile; and (b) analyze the effects of 16 weeks of two HIIT protocols (1-bout 1&#x000d7;4 min vs. HIIT 4&#x000d7;4 min) on metabolic and inflammatory profile of subjects with overweight and obesity.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Participants</title><p>Subjects with overweight and obesity (body mass index&#x02265;25 kg/m<sup>2</sup>) were invited to participate in the study through dissemination of the project in social networks, printed posters, emails list from students and employees at the University of Sao Paulo - Campus of Ribeirao Preto, patients list of Hospital&#x02019;s Ribeirao Preto Medical School, University of S&#x000e3;o Paulo, radio, and television stations.</p><p>In this study, subjects of both genders (women and men), aged 18 years old or more, was randomized and stratified into three groups: HIIT 3 times a week, 4&#x000d7;4 min (HIIT); &#x0201c;one bout&#x0201d; training 3 times a week, 1&#x000d7;4 min (1-bout); and continuous training (CONT) (30 min, 5 times a week). The criteria for exclusion were: unstable angina, recent heart attack (4 weeks), decompensated heart failure, severe valvular disease, uncontrolled hypertension, renal failure, orthopedic/neurological limitations, cardiomyopathy, presence of surgeries planned during the study period, reluctance to sign the consent form and informed participation in another study, and alcohol or drug abuse. The characteristics of each group at baseline are presented in <xref rid="t1-jer-12-6-575" ref-type="table">Table 1</xref>.</p></sec><sec><title>Training program</title><p>HIIT and 1-bout programs were carried out by walking/running 3 times a week on a treadmill. Warming up consisted of 10 min at 70% of maximum heart rate (HR<sub>max</sub>) (13 on Borg scale of 6 to 20 points). Afterwards subjects performed four (HIIT) or a unique (1-bout) period of four minutes at 90% of HR<sub>max</sub> (16 on Borg scale). On the HIIT session the bouts were interspersed by 3 min of active recovery (70% of HR<sub>max</sub>). Finally, both groups, there were 5 min cool down. The CONT corresponded to 70% of HR<sub>max</sub> (13 on Borg scale) for 30 min, 5 times a week. The duration of all three training programs was 16 weeks being the faults recorded and heart rate monitored continuously during the sessions supervised to ensure that the subjects exercised at the correct intensity (<xref rid="b31-jer-12-6-575" ref-type="bibr">Tj&#x000f8;nna et al., 2008</xref>).</p></sec><sec><title>Immunoassays for cytokines</title><p>Blood samples was collected by venipuncture in the antecubital fossa and collected 10 mL of blood that were centrifuged at 3,000 rpm for 8 min at 4&#x000b0;C to separated serum and plasma, and then stored in aliquots at &#x02212;80&#x000b0;C for future analysis. Analysis of cytokines were performed by Enzyme immunoassay ELISA (enzyme-linked immunosorbent assay) using a microplate reader by SpectraMax Plus 384 Absorbance Microplate Reader (San Diego, CA, USA) with a 450 nm filter for reading absorbance.</p><p>Analysis of TNF-&#x003b1;, IL-6 and adiponectin concentrations was performed using reagents kits from R&#x00026;D System (R&#x00026;D System Inc, Minneapolis, MN, USA) with sensitivity of 1,000 to 15.6 pg/mL, 300 to 4.7 pg/mL, and 4,000 to 62.5 pg/mL, respectively. The intra-assay variability of the TNF-&#x003b1; kit was 4.2 to 5.2%; IL-6 kit was 1.6 to 4.2% and adiponectin kit was 0.6 to 6.0%.</p><p>For the analysis of circulating IL-10 concentrations the reagent kits from eBioscience (Affymetrix Inc,, San Diego, CA, USA) was used, with sensitivity of 300 to 2.3 pg/mL, intra-assay variability was 0.3 to 1.0%. Analysis of insulin concentrations was performed using reagents kits from Accubind (Monobind Inc., Lake Forest, CA, USA) with sensitivity of 0 to 300 &#x003bc;lU/mL, intra-assay variability was 4.3 to 8.3%.</p></sec><sec><title>Statistical analysis</title><p>Data normality was verified by the Shapiro&#x02013;Wilks test. To evaluate the effect of training the Student t-test was applied between pre and post 16 weeks in each group. To verify possible differences between baseline (pretraining), as well as the magnitude of the variations (&#x00394;) after training among the three groups we used the one-way analysis of variance. For all analyzes, we used the SPSS ver. 13.0 (SPSS Inc., Chicago, IL, USA). A significance level of 5% was adopted.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>The modification of total body mass and body mass index before and after training are presented in <xref rid="t2-jer-12-6-575" ref-type="table">Table 2</xref>. None group promoted significant changes in body composition of participants, however the HIIT group tended to reduce the total body weight and BMI (<italic>P</italic>=0.059 and <italic>P</italic>= 0.060, respectively).</p><p>Blood measurements of plasma cytokines and insulin are shown in <xref rid="t3-jer-12-6-575" ref-type="table">Table 3</xref>. In HIIT group IL-6 concentrations decreased (<italic>P</italic>= 0.035) in contrast to TNF-&#x003b1; that increased (<italic>P</italic>=0.001) with training. In CONT group TNF-&#x003b1; blood values reduced (<italic>P</italic>=0.037) after the training period. The plasma concentrations of adiponectin decreased significantly in all three groups (<italic>P</italic>=0.009, <italic>P</italic>=0.022, and <italic>P</italic>=0.0002 in CONT, 1-bout, and HIIT, respectively), but there was no difference in magnitude (&#x00394;%) of these changes between group (&#x00394;% CONT=&#x02212;43.7&#x000b1;25.6; &#x00394;% 1&#x000d7;4 min=&#x02212;28.9&#x000b1; 74.9; &#x00394;%=&#x02212;66.3&#x000b1;15.5 HIIT). With the exception of adiponectin, the 1-bout training did not cause any other changes in the evaluated parameters. IL-10, insulin, and homeostasis model assessment insulin resistance (HOMA-IR) did not change across the three training models.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The aim of the present study was to evaluate the effect of 16 weeks of different models of exercise training on metabolic and inflammatory profile of subjects with overweight and obesity. The main findings were that 16 weeks of training on a treadmill (a) reduced IL-6 in the HIIT-4&#x000d7;4 min group, (b) increased TNF-&#x003b1; in HIIT-4&#x000d7;4 min group and reduced it in CONT, and (c) reduced adiponectin levels in all groups.</p><p>Exercise causes great changes in cellular energy status and immune system. The elevated IL-6 production by skeletal muscle during training sessions performs important functions for auxiliary energy supply, stimulating lipolysis in situations of high adenosine monophosphate/adenosine triphosphate ratio and low glycogen stores (<xref rid="b24-jer-12-6-575" ref-type="bibr">Pedersen, 2012</xref>). It also acts on anti-inflammatory form, promoting IL-10 production, which in turn inhibits the action of nuclear factor kappa B, and therefore the synthesis of pro-inflammatory cytokines such as TNF-&#x003b1; and interleukin-1&#x003b2; (<xref rid="b7-jer-12-6-575" ref-type="bibr">Galic et al., 2010</xref>).</p><p>In a recent study <xref rid="b1-jer-12-6-575" ref-type="bibr">Cabral-Santos et al. (2015)</xref> showed that IL-6 concentrations are significantly elevated after high intensity intermittent stimulus (5 km performed 1:1 100% of VO<sub>2peak</sub> [peak oxygen consumption]) when compared to continuous moderate intensity. This may be due to increased demand for glucose, as evidenced by the high blood lactate concentrations usually found in these training models. <xref rid="b32-jer-12-6-575" ref-type="bibr">Tschakert et al. (2015)</xref> reported that in a protocol in cycle ergometer (4&#x000d7;4 min - 95% of HR<sub>max</sub>) similar to the present study HIIT the blood lactate concentrations and respiratory exchange ratio were significantly higher than in the lower intensity continuous. These data indicate the highest metabolic stress generated in HIIT favoring greater IL-6 production.</p><p>Unlike the exercise, at rest approximately 30% of circulating IL-6 comes from the adipose tissue and that total two-thirds of infiltrated macrophages (<xref rid="b6-jer-12-6-575" ref-type="bibr">Fried et al., 1998</xref>; <xref rid="b23-jer-12-6-575" ref-type="bibr">Mohamed-Ali et al., 1997</xref>). It is important to consider that the IL-6 is also considered to be the main inducer of the expression of several proteins that play an important role on inflammatory status. High plasma concentrations of IL-6 together with C-reactive protein, fibrinogen, and amyloid A are related to chronic low-grade inflammation and involved with the development of some diseases, such as diabetes, atherosclerosis, and rheumatoid arthritis (<xref rid="b25-jer-12-6-575" ref-type="bibr">Reihmane and Dela, 2014</xref>). Thus, the present study showed that 16 weeks of HIIT training reduced IL-6 concentration in overweight/obeses subjects. This result can be understood as a supportive and protective adaptation to these diseases.</p><p>Obesity is associated with a sedentary lifestyle and high caloric intake. These lifestyle habits promote the adipocyte hypertrophy, which decreases blood and oxygen supply to the adipose tissue. This chronic and progressive reduction stimulates the recruitment of monocytes and secretion of pro-inflammatory cytokines, such as IL-6 and TNF-&#x003b1; (<xref rid="b9-jer-12-6-575" ref-type="bibr">Gleeson et al., 2011</xref>). TNF-&#x003b1; is a cytokine produced primarily by monocytes and macrophages infiltration in adipose tissue. However, other immune cells, such as lymphocytes and natural killer cells, may also produce it. High concentration of TNF-&#x003b1; is usually associated with cell death, cardiovascular diseases, inflammation and other acute phase proteins (<xref rid="b10-jer-12-6-575" ref-type="bibr">Golbidi and Laher, 2014</xref>). This cytokine also activates certain intracellular kinases, which inhibit the signaling of insulin, impairing glucose uptake (<xref rid="b5-jer-12-6-575" ref-type="bibr">Diehl, 2004</xref>).</p><p>The <xref rid="b16-jer-12-6-575" ref-type="bibr">Leggate et al.&#x02019;s (2012)</xref> study with overweight/obese men showed that 2-week HIIT not alter the blood concentrations of IL-6, IL-10, and TNF-&#x003b1;. On the other hand, adipose tissue concentrations of monocyte chemoattractant protein-1, IL-10, and TNF-&#x003b1; were undetectable after training, indicating beneficial adaptations in the resting inflammatory profile. <xref rid="b27-jer-12-6-575" ref-type="bibr">Robinson et al. (2015)</xref> evaluated the effects of HIIT and continuous in the same population (predominantly obese women) and also found an improvement in inflammatory profile indicated by the decrease of Toll-like receptors type 4 (lymphocytes and monocytes) and type 2 (lymphocytes), membrane receptors known to be related to inflammatory response, even without changes in blood cytokines.</p><p>In light of this knowledge, the reduction of circulating TNF-&#x003b1; after 16 weeks of CONT training can be beneficial, but we cannot claim that the increase in circulating TNF-&#x003b1; post HIIT is harmful because it is known that blood concentrations can not accurately reflect the intracellular and tissue reality. In addition these changes did not alter the concentrations of insulin and HOMA-IR values, suggesting that insulin sensitivity was not affected by different concentrations of TNF-&#x003b1;.</p><p>Another issue to consider is that the action of TNF-&#x003b1;, as well as its efficiency, are dependent on their receivers. In cell membrane there are two types of receptors (TNFR1 and 2) and pro-inflammatory characteristics generally associated with the protein (mainly in adipose tissue) are past their binding to TNFR1. These receptors may also be cleaved and become soluble in plasma (sTNFR) and thus act in on anti-inflammatory form, binding to TNF-&#x003b1; and prevent its connection to the cell membrane and subsequent signal transduction (<xref rid="b2-jer-12-6-575" ref-type="bibr">Cawthorn and Sethi, 2008</xref>; <xref rid="b8-jer-12-6-575" ref-type="bibr">Gatanaga et al., 1990</xref>; <xref rid="b19-jer-12-6-575" ref-type="bibr">MacEwan, 2002</xref>). So, if TNF-&#x003b1; post HIIT increases are accompanied by the increase of sTNFR, the functions of this protein can be suppressed. More studies are need for better understanding of mechanism involved.</p><p>Another variable analyzed was adiponectin. Studies showed that it is reduced in situations of obesity and insulin resistance when compared to healthy individuals and animals (<xref rid="b12-jer-12-6-575" ref-type="bibr">Hu et al., 1996</xref>; <xref rid="b36-jer-12-6-575" ref-type="bibr">Weyer et al., 2001</xref>). Weight loss and exercise are common treatments for improvement in insulin sensitivity, but <xref rid="b13-jer-12-6-575" ref-type="bibr">Hulver et al. (2002)</xref> showed that only the weight loss is effective for increased in the adiponectine levels. Suggesting that exercise training improves insulin sensitivity by independent mechanisms for weight loss and adiponectin action. <xref rid="b20-jer-12-6-575" ref-type="bibr">Madsen et al. (2008)</xref> showed that an increase in adiponectine levels requires a reduction of at least 10% in total body mass. Another study by <xref rid="b3-jer-12-6-575" ref-type="bibr">Christiansen et al. (2010)</xref> found conflicting results showing augment of adiponectin only in the groups that performed restrictive diet and diet coupled with aerobic exercise for 12 weeks. In this study there was also a third group that performed only exercises without calorie restriction, with smaller reduction in fat mass and no significant decrease in adiponectine levels.</p><p>A review by <xref rid="b29-jer-12-6-575" ref-type="bibr">Simpson and Singh (2008)</xref> showed that only three of eight studies with exercise increased adiponectine levels. Despite the benefits of this adipokine in increased insulin sensitivity, it is important to note that there are different isoforms of adiponectin with not entirely clear functions, and exercise seems to regulate differently each isoform. Other studies may want to verify whether different exercise intensity modulates adiponectin.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>Fabio Santos Lira thanks Funda&#x000e7;ao de Amparo &#x000e0; Pesquisa do Estado de Sao Paulo - Fapesp for their support (2013/25310-2).</p></ack><fn-group><fn id="fn1-jer-12-6-575"><p>CONFLICT OF INTEREST</p><p>No potential conflict of interest relevant to this article was reported.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="b1-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabral-Santos</surname><given-names>C</given-names></name><name><surname>Gerosa-Neto</surname><given-names>J</given-names></name><name><surname>Inoue</surname><given-names>DS</given-names></name><name><surname>Panissa</surname><given-names>VL</given-names></name><name><surname>Gobbo</surname><given-names>LA</given-names></name><name><surname>Zagatto</surname><given-names>AM</given-names></name><name><surname>Campos</surname><given-names>EZ</given-names></name><name><surname>Lira</surname><given-names>FS</given-names></name></person-group><article-title>Similar Anti-Inflammatory Acute responses from moderate-intensity continuous and high-intensity intermittent exercise</article-title><source>J Sports Sci Med</source><year>2015</year><volume>14</volume><fpage>849</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">26664283</pub-id></element-citation></ref><ref id="b2-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cawthorn</surname><given-names>WP</given-names></name><name><surname>Sethi</surname><given-names>JK</given-names></name></person-group><article-title>TNF-alpha and adipocyte biology</article-title><source>FEBS Lett</source><year>2008</year><volume>582</volume><fpage>117</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">18037376</pub-id></element-citation></ref><ref id="b3-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christiansen</surname><given-names>T</given-names></name><name><surname>Paulsen</surname><given-names>SK</given-names></name><name><surname>Bruun</surname><given-names>JM</given-names></name><name><surname>Ploug</surname><given-names>T</given-names></name><name><surname>Pedersen</surname><given-names>SB</given-names></name><name><surname>Richelsen</surname><given-names>B</given-names></name></person-group><article-title>Diet-induced weight loss and exercise alone and in combination enhance the expression of adiponectin receptors in adipose tissue and skeletal muscle, but only diet-induced weight loss enhanced circulating adiponectin</article-title><source>J Clin Endocrinol Metab</source><year>2010</year><volume>95</volume><fpage>911</fpage><lpage>919</lpage><pub-id pub-id-type="pmid">19996310</pub-id></element-citation></ref><ref id="b4-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Meirelles</surname><given-names>LR</given-names></name><name><surname>Matsuura</surname><given-names>C</given-names></name><name><surname>de Resende</surname><given-names>AC</given-names></name><name><surname>Salgado</surname><given-names>AA</given-names></name><name><surname>Pereira</surname><given-names>NR</given-names></name><name><surname>Coscarelli</surname><given-names>PG</given-names></name><name><surname>Mendes-Ribeiro</surname><given-names>AC</given-names></name><name><surname>Brunini</surname><given-names>TM</given-names></name></person-group><article-title>Chronic exercise leads to antiaggregant, antioxidant and anti-inflammatory effects in heart failure patients</article-title><source>Eur J Prev Cardiol</source><year>2014</year><volume>21</volume><fpage>1225</fpage><lpage>1232</lpage><pub-id pub-id-type="pmid">23695648</pub-id></element-citation></ref><ref id="b5-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diehl</surname><given-names>AM</given-names></name></person-group><article-title>Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease</article-title><source>Clin Liver Dis</source><year>2004</year><volume>8</volume><fpage>619</fpage><lpage>638</lpage><pub-id pub-id-type="pmid">15331067</pub-id></element-citation></ref><ref id="b6-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fried</surname><given-names>SK</given-names></name><name><surname>Bunkin</surname><given-names>DA</given-names></name><name><surname>Greenberg</surname><given-names>AS</given-names></name></person-group><article-title>Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid</article-title><source>J Clin Endocrinol Metab</source><year>1998</year><volume>83</volume><fpage>847</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">9506738</pub-id></element-citation></ref><ref id="b7-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galic</surname><given-names>S</given-names></name><name><surname>Oakhill</surname><given-names>JS</given-names></name><name><surname>Steinberg</surname><given-names>GR</given-names></name></person-group><article-title>Adipose tissue as an endocrine organ</article-title><source>Mol Cell Endocrinol</source><year>2010</year><volume>316</volume><fpage>129</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">19723556</pub-id></element-citation></ref><ref id="b8-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatanaga</surname><given-names>T</given-names></name><name><surname>Hwang</surname><given-names>CD</given-names></name><name><surname>Kohr</surname><given-names>W</given-names></name><name><surname>Cappuccini</surname><given-names>F</given-names></name><name><surname>Lucci</surname><given-names>JA</given-names><suffix>3rd</suffix></name><name><surname>Jeffes</surname><given-names>EW</given-names></name><name><surname>Lentz</surname><given-names>R</given-names></name><name><surname>Tomich</surname><given-names>J</given-names></name><name><surname>Yamamoto</surname><given-names>RS</given-names></name><name><surname>Granger</surname><given-names>GA</given-names></name></person-group><article-title>Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients</article-title><source>Proc Natl Acad Sci U S A</source><year>1990</year><volume>87</volume><fpage>8781</fpage><lpage>8784</lpage><pub-id pub-id-type="pmid">2174164</pub-id></element-citation></ref><ref id="b9-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gleeson</surname><given-names>M</given-names></name><name><surname>Bishop</surname><given-names>NC</given-names></name><name><surname>Stensel</surname><given-names>DJ</given-names></name><name><surname>Lindley</surname><given-names>MR</given-names></name><name><surname>Mastana</surname><given-names>SS</given-names></name><name><surname>Nimmo</surname><given-names>MA</given-names></name></person-group><article-title>The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease</article-title><source>Nat Rev Immunol</source><year>2011</year><volume>11</volume><fpage>607</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">21818123</pub-id></element-citation></ref><ref id="b10-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golbidi</surname><given-names>S</given-names></name><name><surname>Laher</surname><given-names>I</given-names></name></person-group><article-title>Exercise induced adipokine changes and the metabolic syndrome</article-title><source>J Diabetes Res</source><year>2014</year><volume>2014</volume><fpage>726861</fpage><pub-id pub-id-type="pmid">24563869</pub-id></element-citation></ref><ref id="b11-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotta</surname><given-names>K</given-names></name><name><surname>Funahashi</surname><given-names>T</given-names></name><name><surname>Arita</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>Okamoto</surname><given-names>Y</given-names></name><name><surname>Iwahashi</surname><given-names>H</given-names></name><name><surname>Kuriyama</surname><given-names>H</given-names></name><name><surname>Ouchi</surname><given-names>N</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name><name><surname>Nishida</surname><given-names>M</given-names></name><name><surname>Kihara</surname><given-names>S</given-names></name><name><surname>Sakai</surname><given-names>N</given-names></name><name><surname>Nakajima</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Muraguchi</surname><given-names>M</given-names></name><name><surname>Ohmoto</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Yamashita</surname><given-names>S</given-names></name><name><surname>Hanafusa</surname><given-names>T</given-names></name><name><surname>Matsuzawa</surname><given-names>Y</given-names></name></person-group><article-title>Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2000</year><volume>20</volume><fpage>1595</fpage><lpage>1599</lpage><pub-id pub-id-type="pmid">10845877</pub-id></element-citation></ref><ref id="b12-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>E</given-names></name><name><surname>Liang</surname><given-names>P</given-names></name><name><surname>Spiegelman</surname><given-names>BM</given-names></name></person-group><article-title>AdipoQ is a novel adipose-specific gene dysregulated in obesity</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>10697</fpage><lpage>10703</lpage><pub-id pub-id-type="pmid">8631877</pub-id></element-citation></ref><ref id="b13-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulver</surname><given-names>MW</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Tanner</surname><given-names>CJ</given-names></name><name><surname>Houmard</surname><given-names>JA</given-names></name><name><surname>Kraus</surname><given-names>WE</given-names></name><name><surname>Slentz</surname><given-names>CA</given-names></name><name><surname>Sinha</surname><given-names>MK</given-names></name><name><surname>Pories</surname><given-names>WJ</given-names></name><name><surname>MacDonald</surname><given-names>KG</given-names></name><name><surname>Dohm</surname><given-names>GL</given-names></name></person-group><article-title>Adiponectin is not altered with exercise training despite enhanced insulin action</article-title><source>Am J Physiol Endocrinol Metab</source><year>2002</year><volume>283</volume><fpage>E861</fpage><lpage>865</lpage><pub-id pub-id-type="pmid">12217905</pub-id></element-citation></ref><ref id="b14-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karstoft</surname><given-names>K</given-names></name><name><surname>Pedersen</surname><given-names>BK</given-names></name></person-group><article-title>Exercise and type 2 diabetes: focus on metabolism and inflammation</article-title><source>Immunol Cell Biol</source><year>2016</year><volume>94</volume><fpage>146</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">26568029</pub-id></element-citation></ref><ref id="b15-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lara-Castro</surname><given-names>C</given-names></name><name><surname>Luo</surname><given-names>N</given-names></name><name><surname>Wallace</surname><given-names>P</given-names></name><name><surname>Klein</surname><given-names>RL</given-names></name><name><surname>Garvey</surname><given-names>WT</given-names></name></person-group><article-title>Adiponectin multimeric complexes and the metabolic syndrome trait cluster</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>249</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">16380500</pub-id></element-citation></ref><ref id="b16-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leggate</surname><given-names>M</given-names></name><name><surname>Carter</surname><given-names>WG</given-names></name><name><surname>Evans</surname><given-names>MJ</given-names></name><name><surname>Vennard</surname><given-names>RA</given-names></name><name><surname>Sribala-Sundaram</surname><given-names>S</given-names></name><name><surname>Nimmo</surname><given-names>MA</given-names></name></person-group><article-title>Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high-intensity intermittent training in overweight and obese males</article-title><source>J Appl Physiol (1985)</source><year>2012</year><volume>112</volume><fpage>1353</fpage><lpage>1360</lpage><pub-id pub-id-type="pmid">22267387</pub-id></element-citation></ref><ref id="b17-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lira</surname><given-names>FS</given-names></name><name><surname>de Antunes</surname><given-names>BM</given-names></name><name><surname>Seelaender</surname><given-names>M</given-names></name><name><surname>Rosa Neto</surname><given-names>JC</given-names></name></person-group><article-title>The therapeutic potential of exercise to treat cachexia</article-title><source>Curr Opin Support Palliat Care</source><year>2015</year><volume>9</volume><fpage>317</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">26509857</pub-id></element-citation></ref><ref id="b18-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lira</surname><given-names>FS</given-names></name><name><surname>Rosa</surname><given-names>JC</given-names></name><name><surname>Lima-Silva</surname><given-names>AE</given-names></name><name><surname>Souza</surname><given-names>HA</given-names></name><name><surname>Caperuto</surname><given-names>EC</given-names></name><name><surname>Seelaender</surname><given-names>MC</given-names></name><name><surname>Damaso</surname><given-names>AR</given-names></name><name><surname>Oyama</surname><given-names>LM</given-names></name><name><surname>Santos</surname><given-names>RV</given-names></name></person-group><article-title>Sedentary subjects have higher PAI-1 and lipoproteins levels than highly trained athletes</article-title><source>Diabetol Metab Syndr</source><year>2010</year><volume>2</volume><fpage>7</fpage><pub-id pub-id-type="pmid">20205861</pub-id></element-citation></ref><ref id="b19-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacEwan</surname><given-names>DJ</given-names></name></person-group><article-title>TNF receptor subtype signalling: differences and cellular consequences</article-title><source>Cell Signal</source><year>2002</year><volume>14</volume><fpage>477</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">11897488</pub-id></element-citation></ref><ref id="b20-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname><given-names>EL</given-names></name><name><surname>Rissanen</surname><given-names>A</given-names></name><name><surname>Bruun</surname><given-names>JM</given-names></name><name><surname>Skogstrand</surname><given-names>K</given-names></name><name><surname>Tonstad</surname><given-names>S</given-names></name><name><surname>Hougaard</surname><given-names>DM</given-names></name><name><surname>Richelsen</surname><given-names>B</given-names></name></person-group><article-title>Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study</article-title><source>Eur J Endocrinol</source><year>2008</year><volume>158</volume><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">18230824</pub-id></element-citation></ref><ref id="b21-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname><given-names>SM</given-names></name><name><surname>Thorup</surname><given-names>AC</given-names></name><name><surname>Bjerre</surname><given-names>M</given-names></name><name><surname>Jeppesen</surname><given-names>PB</given-names></name></person-group><article-title>Does 8 weeks of strenuous bicycle exercise improve diabetes-related inflammatory cytokines and free fatty acids in type 2 diabetes patients and individuals at high-risk of metabolic syndrome?</article-title><source>Arch Physiol Biochem</source><year>2015a</year><volume>121</volume><fpage>129</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">26469542</pub-id></element-citation></ref><ref id="b22-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname><given-names>SM</given-names></name><name><surname>Thorup</surname><given-names>AC</given-names></name><name><surname>Overgaard</surname><given-names>K</given-names></name><name><surname>Bjerre</surname><given-names>M</given-names></name><name><surname>Jeppesen</surname><given-names>PB</given-names></name></person-group><article-title>Functional and structural vascular adaptations following 8 weeks of low volume high intensity interval training in lower leg of type 2 diabetes patients and individuals at high risk of metabolic syndrome</article-title><source>Arch Physiol Biochem</source><year>2015b</year><volume>121</volume><fpage>178</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">26471849</pub-id></element-citation></ref><ref id="b23-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed-Ali</surname><given-names>V</given-names></name><name><surname>Goodrick</surname><given-names>S</given-names></name><name><surname>Rawesh</surname><given-names>A</given-names></name><name><surname>Katz</surname><given-names>DR</given-names></name><name><surname>Miles</surname><given-names>JM</given-names></name><name><surname>Yudkin</surname><given-names>JS</given-names></name><name><surname>Klein</surname><given-names>S</given-names></name><name><surname>Coppack</surname><given-names>SW</given-names></name></person-group><article-title>Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo</article-title><source>J Clin Endocrinol Metab</source><year>1997</year><volume>82</volume><fpage>4196</fpage><lpage>4200</lpage><pub-id pub-id-type="pmid">9398739</pub-id></element-citation></ref><ref id="b24-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>BK</given-names></name></person-group><article-title>Muscular interleukin-6 and its role as an energy sensor</article-title><source>Med Sci Sports Exerc</source><year>2012</year><volume>44</volume><fpage>392</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">21799452</pub-id></element-citation></ref><ref id="b25-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reihmane</surname><given-names>D</given-names></name><name><surname>Dela</surname><given-names>F</given-names></name></person-group><article-title>Interleukin-6: possible biological roles during exercise</article-title><source>Eur J Sport Sci</source><year>2014</year><volume>14</volume><fpage>242</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">24655147</pub-id></element-citation></ref><ref id="b26-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renaldi</surname><given-names>O</given-names></name><name><surname>Pramono</surname><given-names>B</given-names></name><name><surname>Sinorita</surname><given-names>H</given-names></name><name><surname>Purnomo</surname><given-names>LB</given-names></name><name><surname>Asdie</surname><given-names>RH</given-names></name><name><surname>Asdie</surname><given-names>AH</given-names></name></person-group><article-title>Hypoadiponectinemia: a risk factor for metabolic syndrome</article-title><source>Acta Med Indones</source><year>2009</year><volume>41</volume><fpage>20</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">19258676</pub-id></element-citation></ref><ref id="b27-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>E</given-names></name><name><surname>Durrer</surname><given-names>C</given-names></name><name><surname>Simtchouk</surname><given-names>S</given-names></name><name><surname>Jung</surname><given-names>ME</given-names></name><name><surname>Bourne</surname><given-names>JE</given-names></name><name><surname>Voth</surname><given-names>E</given-names></name><name><surname>Little</surname><given-names>JP</given-names></name></person-group><article-title>Short-term high-intensity interval and moderate-intensity continuous training reduce leukocyte TLR4 in inactive adults at elevated risk of type 2 diabetes</article-title><source>J Appl Physiol (1985)</source><year>2015</year><volume>119</volume><fpage>508</fpage><lpage>516</lpage><pub-id pub-id-type="pmid">26139217</pub-id></element-citation></ref><ref id="b28-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sijie</surname><given-names>T</given-names></name><name><surname>Hainai</surname><given-names>Y</given-names></name><name><surname>Fengying</surname><given-names>Y</given-names></name><name><surname>Jianxiong</surname><given-names>W</given-names></name></person-group><article-title>High intensity interval exercise training in overweight young women</article-title><source>J Sports Med Phys Fitness</source><year>2012</year><volume>52</volume><fpage>255</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">22648463</pub-id></element-citation></ref><ref id="b29-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>KA</given-names></name><name><surname>Singh</surname><given-names>MA</given-names></name></person-group><article-title>Effects of exercise on adiponectin: a systematic review</article-title><source>Obesity (Silver Spring)</source><year>2008</year><volume>16</volume><fpage>241</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">18239630</pub-id></element-citation></ref><ref id="b30-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talanian</surname><given-names>JL</given-names></name><name><surname>Galloway</surname><given-names>SD</given-names></name><name><surname>Heigenhauser</surname><given-names>GJ</given-names></name><name><surname>Bonen</surname><given-names>A</given-names></name><name><surname>Spriet</surname><given-names>LL</given-names></name></person-group><article-title>Two weeks of high-intensity aerobic interval training increases the capacity for fat oxidation during exercise in women</article-title><source>J Appl Physiol (1985)</source><year>2007</year><volume>102</volume><fpage>1439</fpage><lpage>1447</lpage><pub-id pub-id-type="pmid">17170203</pub-id></element-citation></ref><ref id="b31-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tj&#x000f8;nna</surname><given-names>AE</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Rognmo</surname><given-names>&#x000d8;</given-names></name><name><surname>St&#x000f8;len</surname><given-names>TO</given-names></name><name><surname>Bye</surname><given-names>A</given-names></name><name><surname>Haram</surname><given-names>PM</given-names></name><name><surname>Loennechen</surname><given-names>JP</given-names></name><name><surname>Al-Share</surname><given-names>QY</given-names></name><name><surname>Skogvoll</surname><given-names>E</given-names></name><name><surname>Sl&#x000f8;rdahl</surname><given-names>SA</given-names></name><name><surname>Kemi</surname><given-names>OJ</given-names></name><name><surname>Najjar</surname><given-names>SM</given-names></name><name><surname>Wisl&#x000f8;ff</surname><given-names>U</given-names></name></person-group><article-title>Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study</article-title><source>Circulation</source><year>2008</year><volume>118</volume><fpage>346</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">18606913</pub-id></element-citation></ref><ref id="b32-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschakert</surname><given-names>G</given-names></name><name><surname>Kroepfl</surname><given-names>J</given-names></name><name><surname>Mueller</surname><given-names>A</given-names></name><name><surname>Moser</surname><given-names>O</given-names></name><name><surname>Groeschl</surname><given-names>W</given-names></name><name><surname>Hofmann</surname><given-names>P</given-names></name></person-group><article-title>How to regulate the acute physiological response to &#x0201c;aerobic&#x0201d; high-intensity interval exercise</article-title><source>J Sports Sci Med</source><year>2015</year><volume>14</volume><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">25729286</pub-id></element-citation></ref><ref id="b33-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vilarrasa</surname><given-names>N</given-names></name><name><surname>Vendrell</surname><given-names>J</given-names></name><name><surname>Maravall</surname><given-names>J</given-names></name><name><surname>Broch</surname><given-names>M</given-names></name><name><surname>Estepa</surname><given-names>A</given-names></name><name><surname>Megia</surname><given-names>A</given-names></name><name><surname>Soler</surname><given-names>J</given-names></name><name><surname>Sim&#x000f3;n</surname><given-names>I</given-names></name><name><surname>Richart</surname><given-names>C</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>JM</given-names></name></person-group><article-title>Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population</article-title><source>Clin Endocrinol (Oxf)</source><year>2005</year><volume>63</volume><fpage>329</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">16117822</pub-id></element-citation></ref><ref id="b34-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weghuber</surname><given-names>D</given-names></name><name><surname>Mangge</surname><given-names>H</given-names></name><name><surname>Hochbrugger</surname><given-names>E</given-names></name><name><surname>Stulnig</surname><given-names>TM</given-names></name></person-group><article-title>Impact of age and metabolic syndrome on the adipokine profile in childhood and adult obesity</article-title><source>Exp Clin Endocrinol Diabetes</source><year>2014</year><volume>122</volume><fpage>363</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">24941433</pub-id></element-citation></ref><ref id="b35-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>MJ</given-names></name><name><surname>Hsieh</surname><given-names>CH</given-names></name><name><surname>Wu</surname><given-names>CZ</given-names></name><name><surname>Hsiao</surname><given-names>FC</given-names></name><name><surname>Hsia</surname><given-names>TL</given-names></name><name><surname>Hung</surname><given-names>YJ</given-names></name><name><surname>Pei</surname><given-names>D</given-names></name></person-group><article-title>The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome: A pilot study</article-title><source>Obes Res Clin Pract</source><year>2013</year><volume>7</volume><fpage>e206</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">23697589</pub-id></element-citation></ref><ref id="b36-jer-12-6-575"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weyer</surname><given-names>C</given-names></name><name><surname>Funahashi</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Hotta</surname><given-names>K</given-names></name><name><surname>Matsuzawa</surname><given-names>Y</given-names></name><name><surname>Pratley</surname><given-names>RE</given-names></name><name><surname>Tataranni</surname><given-names>PA</given-names></name></person-group><article-title>Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia</article-title><source>J Clin Endocrinol Metab</source><year>2001</year><volume>86</volume><fpage>1930</fpage><lpage>1935</lpage><pub-id pub-id-type="pmid">11344187</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-jer-12-6-575" orientation="portrait" position="float"><label>Table 1</label><caption><p>Sample characteristics</p></caption><table frame="hsides" rules="rows"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Group</th><th valign="bottom" align="center" rowspan="1" colspan="1">Age (yr)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Height (cm)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">CONT</td><td valign="top" align="left" rowspan="1" colspan="1">50.4&#x000b1;11.6</td><td valign="top" align="left" rowspan="1" colspan="1">160.6&#x000b1;10.5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1-bout</td><td valign="top" align="left" rowspan="1" colspan="1">47.4&#x000b1;11.2</td><td valign="top" align="left" rowspan="1" colspan="1">164.0&#x000b1;7.6</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIIT</td><td valign="top" align="left" rowspan="1" colspan="1">41.4&#x000b1;9.3</td><td valign="top" align="left" rowspan="1" colspan="1">161.5&#x000b1;9.2</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-jer-12-6-575"><p>Values are presented as mean&#x000b1;standard deviation.</p></fn><fn id="tfn2-jer-12-6-575"><p>CONT, continuous training (30 min, 5 days a week); 1-bout, 3 times a week, 1&#x000d7;4 min; HIIT, high intensity interval training (3 times a week, 4&#x000d7;4 min).</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-jer-12-6-575" orientation="portrait" position="float"><label>Table 2</label><caption><p>Body mass and body mass index</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" rowspan="3" align="left" colspan="1">Group</th><th colspan="3" valign="middle" align="center" rowspan="1">Body mass (kg)</th><th colspan="3" valign="middle" align="center" rowspan="1">Body mass index (kg/cm<sup>2</sup>)</th></tr><tr><th colspan="3" valign="middle" align="left" rowspan="1">
<hr/></th><th colspan="3" valign="middle" align="left" rowspan="1">
<hr/></th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">Pre</th><th valign="middle" align="center" rowspan="1" colspan="1">Post</th><th valign="middle" align="center" rowspan="1" colspan="1">%&#x00394;</th><th valign="middle" align="center" rowspan="1" colspan="1">Pr&#x000e9;</th><th valign="middle" align="center" rowspan="1" colspan="1">Post</th><th valign="middle" align="center" rowspan="1" colspan="1">%&#x00394;</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">CONT</td><td valign="top" align="center" rowspan="1" colspan="1">81.3&#x000b1;13.2</td><td valign="top" align="center" rowspan="1" colspan="1">80.1&#x000b1;13.0</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.5&#x000b1;2.7</td><td valign="top" align="center" rowspan="1" colspan="1">31.0&#x000b1;2.5</td><td valign="top" align="center" rowspan="1" colspan="1">30.5&#x000b1;2.4</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.5&#x000b1;2.7</td></tr><tr><td colspan="7" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1-bout</td><td valign="top" align="center" rowspan="1" colspan="1">79.0&#x000b1;10.3</td><td valign="top" align="center" rowspan="1" colspan="1">78.7&#x000b1;11.1</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.6&#x000b1;1.9</td><td valign="top" align="center" rowspan="1" colspan="1">29.4&#x000b1;3.9</td><td valign="top" align="center" rowspan="1" colspan="1">29.3&#x000b1;4.0</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0,6&#x000b1;1.8</td></tr><tr><td colspan="7" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HIIT</td><td valign="top" align="center" rowspan="1" colspan="1">85.6&#x000b1;17.4</td><td valign="top" align="center" rowspan="1" colspan="1">83.2&#x000b1;15.3</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.4&#x000b1;3.3</td><td valign="top" align="center" rowspan="1" colspan="1">32.6&#x000b1;6.2</td><td valign="top" align="center" rowspan="1" colspan="1">31.8&#x000b1;5.8</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.4&#x000b1;3.5</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-jer-12-6-575"><p>Values are presented as mean&#x000b1;standard deviation.</p></fn><fn id="tfn4-jer-12-6-575"><p>CONT, continuous training (30 min, 5 times a week); 1-bout, 3 times a week, 1&#x000d7;4 min; HIIT, high intensity interval training (3 times a week, 4&#x000d7;4 min); %&#x00394;, percentage delta.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-jer-12-6-575" orientation="portrait" position="float"><label>Table 3</label><caption><p>Blood variables and calculation of homeostasis model assessment insulin resistance</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" rowspan="3" align="left" colspan="1">Variable</th><th colspan="3" valign="middle" align="center" rowspan="1">CONT</th><th colspan="3" valign="middle" align="center" rowspan="1">1-bout</th><th colspan="3" valign="middle" align="center" rowspan="1">HIIT</th></tr><tr><th colspan="3" valign="middle" align="left" rowspan="1">
<hr/></th><th colspan="3" valign="middle" align="left" rowspan="1">
<hr/></th><th colspan="3" valign="middle" align="left" rowspan="1">
<hr/></th></tr><tr><th valign="middle" align="center" rowspan="1" colspan="1">Pre</th><th valign="middle" align="center" rowspan="1" colspan="1">Post</th><th valign="middle" align="center" rowspan="1" colspan="1">%&#x00394;</th><th valign="middle" align="center" rowspan="1" colspan="1">Pre</th><th valign="middle" align="center" rowspan="1" colspan="1">Post</th><th valign="middle" align="center" rowspan="1" colspan="1">%&#x00394;</th><th valign="middle" align="center" rowspan="1" colspan="1">Pr&#x000e9;</th><th valign="middle" align="center" rowspan="1" colspan="1">Post</th><th valign="middle" align="center" rowspan="1" colspan="1">%&#x00394;</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">IL-6 (pg/mL)</td><td valign="top" align="center" rowspan="1" colspan="1">2.5&#x000b1;1.0</td><td valign="top" align="center" rowspan="1" colspan="1">2.4&#x000b1;3.0</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;8.8&#x000b1;69.6</td><td valign="top" align="center" rowspan="1" colspan="1">4.4&#x000b1;5.7</td><td valign="top" align="center" rowspan="1" colspan="1">1.8&#x000b1;1.3</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;28.0&#x000b1;66.3</td><td valign="top" align="center" rowspan="1" colspan="1">3.5&#x000b1;2.2<xref rid="tfn7-jer-12-6-575" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2.4&#x000b1;2.0</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;28.8&#x000b1;58.3</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IL-10 (pg/mL)</td><td valign="top" align="center" rowspan="1" colspan="1">3.6&#x000b1;3.5</td><td valign="top" align="center" rowspan="1" colspan="1">3.2&#x000b1;3.0</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;8.6&#x000b1;21.1</td><td valign="top" align="center" rowspan="1" colspan="1">2.3&#x000b1;1.5</td><td valign="top" align="center" rowspan="1" colspan="1">1.7&#x000b1;0.4</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.6&#x000b1;1.5</td><td valign="top" align="center" rowspan="1" colspan="1">1.9&#x000b1;0.8</td><td valign="top" align="center" rowspan="1" colspan="1">2.0&#x000b1;1.3</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.2&#x000b1;20.1</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TNF-&#x003b1; (pg/mL)</td><td valign="top" align="center" rowspan="1" colspan="1">4.3&#x000b1;2.3</td><td valign="top" align="center" rowspan="1" colspan="1">2.3&#x000b1;1.3<xref rid="tfn7-jer-12-6-575" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;35.7&#x000b1;54.7</td><td valign="top" align="center" rowspan="1" colspan="1">2.8&#x000b1;2.7</td><td valign="top" align="center" rowspan="1" colspan="1">3.3&#x000b1;1.5</td><td valign="top" align="center" rowspan="1" colspan="1">138.9&#x000b1;221.6</td><td valign="top" align="center" rowspan="1" colspan="1">2.4&#x000b1;1.3</td><td valign="top" align="center" rowspan="1" colspan="1">4.9&#x000b1;1.6<xref rid="tfn8-jer-12-6-575" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">203.3&#x000b1;275.5</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Adiponectin (&#x003bc;g/dL)</td><td valign="top" align="center" rowspan="1" colspan="1">5.3&#x000b1;2.3</td><td valign="top" align="center" rowspan="1" colspan="1">2.9&#x000b1;1.7<xref rid="tfn8-jer-12-6-575" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;43.7&#x000b1;25.3</td><td valign="top" align="center" rowspan="1" colspan="1">5.9&#x000b1;2.0</td><td valign="top" align="center" rowspan="1" colspan="1">3.2&#x000b1;2.2<xref rid="tfn7-jer-12-6-575" ref-type="table-fn">*</xref></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;28.9&#x000b1;74.9</td><td valign="top" align="center" rowspan="1" colspan="1">5.3&#x000b1;3.0</td><td valign="top" align="center" rowspan="1" colspan="1">1.8&#x000b1;1.7<xref rid="tfn8-jer-12-6-575" ref-type="table-fn">**</xref></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;66.3&#x000b1;15.5</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Insulin (&#x003bc;IU/mL)</td><td valign="top" align="center" rowspan="1" colspan="1">8.0&#x000b1;7.5</td><td valign="top" align="center" rowspan="1" colspan="1">5.8&#x000b1;4.5</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;9.4&#x000b1;37.7</td><td valign="top" align="center" rowspan="1" colspan="1">6.8&#x000b1;9.2</td><td valign="top" align="center" rowspan="1" colspan="1">5.6&#x000b1;6.5</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;6.5&#x000b1;55.4</td><td valign="top" align="center" rowspan="1" colspan="1">4.5&#x000b1;3.9</td><td valign="top" align="center" rowspan="1" colspan="1">3.2&#x000b1;2.0</td><td valign="top" align="center" rowspan="1" colspan="1">21.5&#x000b1;152.4</td></tr><tr><td colspan="10" valign="top" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HOMA-IR</td><td valign="top" align="center" rowspan="1" colspan="1">2.0&#x000b1;1.8</td><td valign="top" align="center" rowspan="1" colspan="1">1.4&#x000b1;1.1</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;6.7&#x000b1;46.7</td><td valign="top" align="center" rowspan="1" colspan="1">1.5&#x000b1;1.9</td><td valign="top" align="center" rowspan="1" colspan="1">1.4&#x000b1;1.8</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;2.5&#x000b1;62.3</td><td valign="top" align="center" rowspan="1" colspan="1">1.1&#x000b1;1.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.7&#x000b1;0.4</td><td valign="top" align="center" rowspan="1" colspan="1">29.2&#x000b1;163.9</td></tr></tbody></table><table-wrap-foot><fn id="tfn5-jer-12-6-575"><p>Values are presented as mean&#x000b1;standard deviation.</p></fn><fn id="tfn6-jer-12-6-575"><p>CONT, continuous training (30 min, 5 times a week); 1-bout, 3 times a week, 1&#x000d7;4 min; HIIT, high intensity interval training (3 times a week, 4&#x000d7;4 min); %&#x00394;, percentage delta; IL, interleukin; TNF-&#x003b1;, tumor necrosis factor-alpha; HOMA-IR, homeostasis model assessment insulin resistance.</p></fn><fn id="tfn7-jer-12-6-575"><label>*</label><p><italic>P</italic>&#x0003c;0.05 and</p></fn><fn id="tfn8-jer-12-6-575"><label>**</label><p><italic>P</italic>&#x0003c;0.01 compared pre and post values.</p></fn></table-wrap-foot></table-wrap></floats-group></article>